Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyriakos A Kirou

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Clinical Immunology (Orlando, Fla.)|April 10, 2013
Anti-interferon alpha treatment in SLEKyriakos A Kirou, Elena Gkrouzman
Current Rheumatology Reports|March 9, 2016
What Causes Lupus Flares?David Fernandez, Kyriakos A Kirou
Annals of the Rheumatic Diseases|January 18, 2022
Hydroxychloroquine and lupus flare: a good drug, but we need to do betterMary K Crow, Kyriakos A Kirou
Biomarkers in Medicine|March 28, 2012
Type I interferons as biomarkers in autoimmune diseasesGeorge D Kalliolias, Kyriakos A Kirou
Arthritis Research & Therapy|September 7, 2010
A new tool for detection of type I interferon activation in systemic lupus erythematosusKyriakos A Kirou, George D Kalliolias
Arthritis Research & Therapy|February 3, 2009
Interferon-induced versus chemokine transcripts as lupus biomarkersMary K Crow, Kyriakos A Kirou
Current Opinion in Rheumatology|August 18, 2004
Interferon-alpha in systemic lupus erythematosusMary K Crow, Kyriakos A Kirou
Current Rheumatology Reports|May 9, 2026
Perioperative Management Considerations for Patients with Systemic Lupus ErythematosusSofia Flouda, Romy Kallas, Kyriakos A Kirou
Transactions of the American Clinical and Climatological Association|September 3, 2015
Identification of Candidate Predictors of Lupus FlareMary K Crow, Mikhail Olferiev, Kyriakos A Kirou
Current Opinion in Immunology|April 15, 2026
New developments and future directions in the management of systemic lupus erythematosusKyriakos A Kirou, Raphael A Kirou, Sofia Flouda
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Clinical Immunology (Orlando, Fla.)|April 10, 2013
Anti-interferon alpha treatment in SLEKyriakos A Kirou, Elena Gkrouzman
Current Rheumatology Reports|March 9, 2016
What Causes Lupus Flares?David Fernandez, Kyriakos A Kirou
Annals of the Rheumatic Diseases|January 18, 2022
Hydroxychloroquine and lupus flare: a good drug, but we need to do betterMary K Crow, Kyriakos A Kirou
Biomarkers in Medicine|March 28, 2012
Type I interferons as biomarkers in autoimmune diseasesGeorge D Kalliolias, Kyriakos A Kirou
Arthritis Research & Therapy|September 7, 2010
A new tool for detection of type I interferon activation in systemic lupus erythematosusKyriakos A Kirou, George D Kalliolias
Arthritis Research & Therapy|February 3, 2009
Interferon-induced versus chemokine transcripts as lupus biomarkersMary K Crow, Kyriakos A Kirou
Current Opinion in Rheumatology|August 18, 2004
Interferon-alpha in systemic lupus erythematosusMary K Crow, Kyriakos A Kirou
Current Rheumatology Reports|May 9, 2026
Perioperative Management Considerations for Patients with Systemic Lupus ErythematosusSofia Flouda, Romy Kallas, Kyriakos A Kirou
Transactions of the American Clinical and Climatological Association|September 3, 2015
Identification of Candidate Predictors of Lupus FlareMary K Crow, Mikhail Olferiev, Kyriakos A Kirou
Current Opinion in Immunology|April 15, 2026
New developments and future directions in the management of systemic lupus erythematosusKyriakos A Kirou, Raphael A Kirou, Sofia Flouda
Pageof 6